Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

222801

Sigma-Aldrich

4-Nitrobenzyl chloroformate

97%, for peptide synthesis

Synonym(s):

(4-Nitrophenyl)methyl carbonochloridate, (4-Nitrophenyl)methyl chloroformate, 4-Nitrobenzyloxycarbonyl chloride, p-Nitrobenzyloxycarbonyl chloride, p-nitrobenzyl chloroformate

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
ClCO2CH2C6H4NO2
CAS Number:
4457-32-3
Molecular Weight:
215.59
Beilstein:
912446
EC Number:
224-708-6
MDL number:
MFCD00007375
UNSPSC Code:
12352101
PubChem Substance ID:
24853356
NACRES:
NA.22

product name

4-Nitrobenzyl chloroformate, 97%

Quality Level

200

Assay

97%

reaction suitability

reaction type: Carbonylations

mp

32-34 °C (lit.)

application(s)

peptide synthesis

storage temp.

2-8°C

SMILES string

[O-][N+](=O)c1ccc(COC(Cl)=O)cc1

InChI

1S/C8H6ClNO4/c9-8(11)14-5-6-1-3-7(4-2-6)10(12)13/h1-4H,5H2

InChI key

MHSGOABISYIYKP-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H314,H335

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 3

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCL5091
BCCJ4791
BCCH6528
BCCD4480
BCCC9199

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

4,5-Dimethoxy-2-nitrobenzyl bromide 97%

Sigma-Aldrich

392855

4,5-Dimethoxy-2-nitrobenzyl bromide

Eun Hyang Jang et al.
International journal of pharmaceutics, 580, 119237-119237 (2020-03-24)
Hypoxia is a characteristic feature of various ischemic diseases, including cancer. This study describes the development of glycol chitosan nanoparticles, hydrophobically modified with 4-nitrobenzyl chloroformate and folic acid (FA), that can specifically release drugs under hypoxic conditions. This hypoxia-responsive glycol

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service